GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alnylam Pharmaceuticals Inc (FRA:DUL) » Definitions » Other Gross PPE

Alnylam Pharmaceuticals (FRA:DUL) Other Gross PPE : €661 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Alnylam Pharmaceuticals Other Gross PPE?

Alnylam Pharmaceuticals's Other Gross PPE for the quarter that ended in Mar. 2024 was €661 Mil.

Alnylam Pharmaceuticals's quarterly Other Gross PPE declined from Sep. 2023 (€683 Mil) to Dec. 2023 (€541 Mil) but then increased from Dec. 2023 (€541 Mil) to Mar. 2024 (€661 Mil).

Alnylam Pharmaceuticals's annual Other Gross PPE increased from Dec. 2021 (€433 Mil) to Dec. 2022 (€542 Mil) but then declined from Dec. 2022 (€542 Mil) to Dec. 2023 (€541 Mil).

Alnylam Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Alnylam Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alnylam Pharmaceuticals Other Gross PPE Chart

Alnylam Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 345.23 395.39 432.60 541.74 541.27

Alnylam Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 689.37 679.58 683.14 541.27 661.41

Alnylam Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Alnylam Pharmaceuticals (FRA:DUL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alnylam Pharmaceuticals Inc (FRA:DUL) » Definitions » Other Gross PPE
Comparable Companies
BGNE BMRN BNTX RPRX SRPT INCY UTHR TECH ROIV LEGN OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX OCSE:GMAB
Traded in Other Exchanges
ALNY:USA ALNY:Mexico DUL:Germany
Address
675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA, USA, 02142
Website
https://www.alnylam.com
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.

Alnylam Pharmaceuticals (FRA:DUL) Headlines

No Headlines